Clinical Trial Update: A Study to Assess the Pharmacokinetics of a Modified-release Tacrolimus Based Immunosuppression Regimen in Stable Liver Transplant Patients [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the pharmacokinetics of a modified-release tacrolimus–based immunosuppression regimen in stable liver transplant recipients has been …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Liver Transplantation

Drugs mentioned

• Advagraf (tacrolimus)

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Liver Transplantation | Phase 2 | Status: COMPLETED | Results posted: 2013-09-30